Ian Watkins - Mallinckrodt Public Insider

MNK -- USA Stock  

USD 19.17  0.34  1.81%

Chief HR Officer and Sr. VP

Mr. Ian J. Watkins is Chief Human Resource Officer of Mallinckrodt Public Limited Company. He has executive responsibility for organizational development, effectiveness and sustainability, talent acquisition, total rewards, and human resources systems and service delivery. He is also responsible for supporting the Board of Directors in their governance activities related to executive compensation, talent and succession management. Mr. Watkins joined Covidiens Pharmaceuticals business in September 2012 as the Chief Human Resources Officer. Mr. Watkins served as Vice President, Global Human Resources at Synthes, Inc. from June 2007 to September 2012, which was acquired by Johnson Johnson. Mr. Watkins served as Senior Vice President, Human Resources from 2003 to 2006 for Andrx Corporationrationration, which is now part of Allergan, Inc.
Age: 54  SVP Since 2016      
44 17 8463 6700  http://www.mallinckrodt.com

Management Efficiency

The company has Return on Asset of 2.18 % which means that on every $100 spent on asset it made $2.18 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 30.63 % implying that it generated $30.63 on every 100 dollars invested.
The company has 6.81 B in debt with debt to equity (D/E) ratio of 105.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. Mallinckrodt Public Limited Company has Current Ratio of 2.06 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Found 4 records

SVP Since

Michael HarringtonEli Lilly and Company
Rita KarachunMerck Co
John ElickerBristol Myers Squibb Company
Paul AutenriedBristol Myers Squibb Company

Entity Summary

Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company is based in Staines-Upon-Thames, the United Kingdom. Mallinckrodt Public operates under Drug Manufacturers - Specialty Generic classification in USA and traded on New York Stock Exchange. It employs 00 people.Mallinckrodt Public Limited Company (MNK) is traded on New York Stock Exchange in USA. It is located in IRELAND and employs 3,900 people. Mallinckrodt Public is listed under Pharmaceutical Products category by Fama And French industry classification.

Mallinckrodt Public Leadership Team

Gary Phillips, President
Steven Romano, President, Ph.D
Mark Casey, Executive
JoAnn Reed, Director
Virgil Thompson, Director
Diane Gulyas, Director
Joseph Zaccagnino, Director
Paul Carter, Director
David Carlucci, Director
Frank Scholz, SVP
David Norton, Director
Hugh ONeill, President
Martin Carroll, Director, MBA
Steve Romano, President, Ph.D
Mark Trudeau, CEO
Kneeland Youngblood, Director, Ph.D
Meredith Fischer, President
Terrance Carlson, President
Ian Watkins, SVP
Melvin Booth, Chairman, Ph.D
Raymond Furey, President
Angus Russell, Director, Ph.D
Ronald Lloyd, President
Karen Sheehy, Executive
Matthew Harbaugh, CFO
MichaelBryant Hicks, Executive
Anne Whitaker, Director

Stock Performance Indicators

Did you try this?

Run Balance Of Power Now

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Balance Of Power

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.